News Bioventus Inc.

Equities

BVS

US09075A1088

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
3.98 ^USD	-2.21%		-11.16%	-24.48%

Mar. 13	Craig-Hallum Adjusts Price Target on Bioventus to $9 From $6, Maintains Buy Rating	MT
Mar. 12	Transcript : Bioventus Inc., Q4 2023 Earnings Call, Mar 12, 2024

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Craig-Hallum Adjusts Price Target on Bioventus to $9 From $6, Maintains Buy Rating	Mar. 13	MT
Bioventus : Q4’23 Earnings Call Slides	Mar. 12	PU
Transcript : Bioventus Inc., Q4 2023 Earnings Call, Mar 12, 2024	Mar. 12
Earnings Flash (BVS) BIOVENTUS Posts Q4 Revenue $135.4M	Mar. 12	MT
Earnings Flash (BVS) BIOVENTUS Reports Q4 EPS $0.07	Mar. 12	MT
Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results	Mar. 12	AQ
Bioventus Inc. Provides Earnings Guidance for the Year 2024	Mar. 12	CI
Bioventus Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 12	CI
Bioventus Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 12	CI
North American Morning Briefing : Inflation Data -2-	Mar. 12	DJ
Bioventus to Report Fourth Quarter of Fiscal Year 2023 Financial Results on March 12, 2024	Mar. 04	AQ
Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility	Jan. 18	AQ
Bioventus Inc. Enters into an Amendment with Its Credit Agreement Lenders to Enhance Financial and Operational Flexibility	Jan. 18	CI
Bioventus Announces Inducement Equity to President and Chief Executive Officer Robert Claypoole	Jan. 12	AQ
BIOVENTUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Bioventus Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm	Dec. 26	BU
Bioventus Hires Robert Claypoole as Chief Executive	Dec. 20	MT
Bioventus Names Robert Claypoole as President and Chief Executive Officer	Dec. 19	AQ
Bioventus Inc Announces Executive Changes	Dec. 18	CI
Bioventus Inc. Announces Executive Changes	Dec. 18	CI
North American Morning Briefing : Futures Pause -2-	Dec. 08	DJ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Bioventus Inc.

Equities

BVS

US09075A1088

Summary

Filters